MedPath

Green Tea Confections For Managing Postprandial Hyperglycemia-Induced Vascular Endothelial Dysfunction

Not Applicable
Completed
Conditions
Cardiovascular Disease
Hyperglycemia
Interventions
Dietary Supplement: Green Tea Concentrate
Registration Number
NCT01857258
Lead Sponsor
Ohio State University
Brief Summary

The objective of this study is to formulate and validate a green tea confection (i.e. "gummy" candy) as a strategy to attenuate postprandial hyperglycemia-induced impairments in vascular function. The central hypothesis is that a green tea confection will protect against vascular endothelial dysfunction by suppressing postprandial hyperglycemia. The central hypothesis of this application will be assessed by developing a green tea-containing confection, examining its physiochemical properties and its inhibition of starch digestion, and then validating its vasoprotective activities in healthy humans by assessing its blood glucose-regulating activities.

Detailed Description

The study involves validating a green tea confection (i.e. "gummy" candy) as a dietary strategy to attenuate postprandial hyperglycemia-induced impairments in vascular function. The central hypothesis is that a green tea confection will protect against vascular endothelial dysfunction by suppressing postprandial hyperglycemia. The central hypothesis of this application will be assessed by providing research participants 75 grams of carbohydrate in the form of a confection that contains no green tea concentrate or green tea concentrate at a level equivalent to approximately 3 cups of freshly brewed tea. Blood glucose and brachial artery flow-mediated dilation will be assessed at regular intervals during the 3 hour postprandial period to define the extent to which green tea attenuates postprandial increases in blood glucose and decreases in vascular function that otherwise occur in a hyperglycemia-dependent manner.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
15
Inclusion Criteria
  • Plasma glucose <100 mg/dL
  • Plasma total cholesterol <200 mg/dL
  • Plasma triglycerides <140 mg/dL
  • Blood pressure <140/90
  • non-dietary supplement user for >2 months
  • no use of medications known to affect carbohydrate metabolism,
  • nonsmoker / never smoker
  • no history of cardiovascular disease or gastrointestinal disorders
Exclusion Criteria
  • allergies or aversions to green tea and/or corn starch,
  • excessive alcohol consumption (>3 drinks/d),
  • >5 h/wk of aerobic activity

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Green TeaGreen Tea ConcentrateParticipants will be provided a confection containing green tea concentrate
ControlGreen Tea ConcentrateParticipants will be provided a confection devoid of green tea concentrate
Primary Outcome Measures
NameTimeMethod
Area Under the Curve of Blood GlucoseArea under the Curve, 0, 30, 60, 90, 120, 150, 180 minutes post-dose

Blood glucose will be measured at 0, 30, 60, 90, 120, 150 and 180 minutes following the ingestion of a confection to calculate area under the concentration-time curve.

Area Under the Curve of Brachial Artery Flow Mediated DilatiionArea under the Curve, 0, 30, 60, 90, 120, 150, 180 minutes post-dose

Brachial artery flow-mediated dilation will be measured at 0, 30, 60, 90, 120, 150, and 180 minutes following the ingestion of a confection.

Brachial Artery Flow-mediated Dilation60 min
Secondary Outcome Measures
NameTimeMethod
Malondialdehyde (0 Min)Baseline (0 min)
Malondialdehyde60 min postprandially
Ratio of Asymmetric Dimethylarginine Relative to Arginine60 min (baseline)

Trial Locations

Locations (1)

The Ohio State University

🇺🇸

Columbus, Ohio, United States

The Ohio State University
🇺🇸Columbus, Ohio, United States
© Copyright 2025. All Rights Reserved by MedPath